CAMP4 Therapeutics (NASDAQ:CAMP) Director Sells 45,147 Shares
MarketBeat
CAMP4 Therapeutics Corporation (NASDAQ:CAMP - Get Free Report) Director Andrew Schwab sold 45,147 shares of the firm's stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $4.76, for a total transaction of $214,899.72. Following the transaction, the director directly owned 2,579,998 shares of the company's stock, valued at $12,280,790.48. The trade was a 1.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
NASDAQ:CAMP
